Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
BNT141 consists of an mRNA encoding an anti-CLDN18.2 monoclonal antibody contained within a lipid nanoparticle, which may lead to inhibition of tumor-expressed CLDN18.2, potentially resulting in tumor cell death (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BNT141 + Gemcitabine + Nab-paclitaxel||BNT141 Gemcitabine Nab-paclitaxel||0||1|